Krsnaa Diagnostics Convertible Warrants

Krsnaa Diagnostics Other Announcement

Krsnaa Diagnostics informs exchanges that its RTA, KFin Technologies, will shift its corporate office effective December 1, 2026. The registered office and the company's own operations are unaffected.

Krsnaa Diagnostics Bags New Order from Municipal Corporation of Delhi

Krsnaa Diagnostics secured a 15-year cash-based PPP project from the Municipal Corporation of Delhi. The contract involves establishing CT Scan and MRI facilities at three public hospitals.

From

Municipal Corporation of Delhi (MCD)

Execution

15 years

diagnostic facilities

3.0 project sites

Krsnaa Diagnostics Earnings Call Transcript: Key Takeaways

Krsnaa hit ₹500 Cr H1 revenue, but heavy Rajasthan ramp-up costs and government receivable delays (₹472 Cr) are squeezing margins and PAT.

Call

Guides 45% growth

Krsnaa Diagnostics Investor Presentation: Key Takeaways

Q2 FY27 revenue INR 2,710 Mn (+32% YoY) and PAT INR 246 Mn (+3%). EBITDA margin fell to 27% from 29% on Rajasthan fixed costs.

Krsnaa Diagnostics Results Update

Krsnaa Diagnostics reported record Q2 revenue of Rs 2,710 million, up 32% year on year. H1 PAT fell to Rs 411 million on Rajasthan project costs.

Krsnaa Diagnostics Q2 FY27 Results: Net Profit ₹24.6 Cr, Up 2.9% YoY

Krsnaa Diagnostics Ltd reported revenue from operations of ₹271 Cr (+31.6% YoY) and net profit of ₹24.6 Cr (+2.9% YoY) for Q2 FY27.

Key figure

Net profit ₹24.6 Cr · +2.9% YoY

Sat Kartar Life Convertible Warrants

Sat Kartar Life received NSE in-principle approval to list 5,50,000 equity shares from warrant conversion. Approval is subject to listing application and allottee undertakings.

Dev Accelerator Convertible Warrants

Dev Accelerator allotted 33,33,330 equity shares to three promoters at Rs.45 each on conversion of warrants. The balance subscription of Rs.11.25 Crore was received.

Value

₹11.25 Cr

Emkay Global Financial Services Convertible Warrants

Emkay Global received NSE and BSE trading approval for 1,00,000 equity shares issued to promoter Prakash Kacholia on conversion of preferential warrants. Shares are admitted to dealings from 4 November 2026, subject to an 18-month lock-in.

AUDROC Convertible Warrants

Audroc submitted the first Monitoring Agency Report for the quarter ended 30 September 2026 on its preferential issue of warrants. Rs.70.39 crore of the Rs.80.00 crore proposed issue had been received, with no deviation from objects.

Value

₹70.39 Cr

U Y Fincorp Convertible Warrants

U. Y. Fincorp seeks EOGM approval on November 25, 2026 to issue 2,45,90,000 warrants worth Rs 59.9996 Crore to promoters. Warrants convert into equity within 18 months.

Value

₹60.00 Cr

Emrock Corporation Convertible Warrants

Emrock allotted 74.35 lakh equity shares on conversion of warrants, receiving Rs.6.13 Crore balance subscription. Listing and trading approvals for the new shares are pending.

Value

₹6.13 Cr